Pizensy patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10806743 BRAINTREE LABS Method of administering lactitol to reduce plasma concentration of lactitol
May, 2037

(13 years from now)

Pizensy is owned by Braintree Labs.

Pizensy contains Lactitol.

Pizensy has a total of 1 drug patent out of which 0 drug patents have expired.

Pizensy was authorised for market use on 12 February, 2020.

Pizensy is available in for solution;oral dosage forms.

Pizensy can be used as method of treating chronic idiopathic constipation in adult patients..

Drug patent challenges can be filed against Pizensy from 2024-02-13.

The generics of Pizensy are possible to be released after 12 May, 2037.

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Feb 12, 2025

Drugs and Companies using LACTITOL ingredient

NCE-1 date: 2024-02-13

Market Authorisation Date: 12 February, 2020

Treatment: Method of treating chronic idiopathic constipation in adult patients.


More Information on Dosage

PIZENSY family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic